MULTIGENE BIOTECH GMBH has a total of 28 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are BIOTRANSPLANT INC, RES INST NATIONWIDE CHILDRENS HOSPITAL and FLAGSHIP PIONEERING INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Germany | 4 | |
#5 | Canada | 3 | |
#6 | Japan | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Agriculture | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Animal care | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Herterich Sabine | 10 |
#2 | Reuter Tanja | 10 |
#3 | Gross Hans Joachim | 10 |
#4 | Weber Bernhard H F | 8 |
#5 | Wagner Matthias | 7 |
#6 | Hoehn Holger | 6 |
#7 | Baiker Armin | 6 |
#8 | Hanenberg Helmut | 6 |
#9 | Piechaczek Christoph | 6 |
#10 | Fetzer Christian | 6 |
Publication | Filing date | Title |
---|---|---|
WO0244366A2 | Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 | |
DE19958680A1 | cDNA sequences of two interactors FANCIP4 and FANCIP5 of the Fanconi anemia proteins of the complementation groups A and C. | |
DE19929887A1 | cDNA sequences of two interacors FANCIP2 and FANCIP3 of the Fanconi anemia protein of complementation group A. | |
EP1035207A1 | cDNA molecules of the members of gene family encoding human fatty acid desaturases and their use in diagnosis and therapy | |
DE19904650A1 | cDNA sequence of an interactor FANCIP1 of the Fanconi anemia protein of complementation group A. | |
EP0999269A1 | CDNA sequence and genomic organization for a 59.4 kDa neuronal-specific 7 transmembrane protein (pNEU60) | |
DE19848017A1 | Episomally replicating vectors, useful in gene therapy, contain origins of replication and scaffold-matrix attached region sequences but no viral coding sequences |